The U.S. Department of Health and Human Services has added Duchenne muscular dystrophy and Metachromatic leukodystrophy to the Recommended Uniform Screening Panel for newborns, a move that advocates say will save lives and empower families. Secretary Kennedy emphasized the importance of early detection and diagnosis for these rare conditions. The announcement has been positively received by companies in the biotech industry, with stocks of Sarepta Therapeutics and Solid Biosciences showing an increase following the news. Congressman Gus Bilirakis also praised the additions, highlighting the critical role of newborn screenings in ensuring healthier futures for children.